- Home
- Publications
- Publication Search
- Publication Details
Title
USP8 modulates ubiquitination of LRIG1 for Met degradation
Authors
Keywords
-
Journal
Scientific Reports
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-05-15
DOI
10.1038/srep04980
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer
- (2013) S. Byun et al. CLINICAL CANCER RESEARCH
- Lrig1: a new master regulator of epithelial stem cells
- (2012) Paloma Ordóñez-Morán et al. EMBO JOURNAL
- A new anti-c-met antibody selected by a mechanism-based dual-screening method: Therapeutic potential in cancer
- (2012) Young Mi Oh et al. MOLECULES AND CELLS
- Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibody
- (2012) J M Lee et al. ONCOGENE
- GGA3 Functions as a Switch to Promote Met Receptor Recycling, Essential for Sustained ERK and Cell Migration
- (2011) Christine Anna Parachoniak et al. DEVELOPMENTAL CELL
- A direct role for Met endocytosis in tumorigenesis
- (2011) Carine Joffre et al. NATURE CELL BIOLOGY
- ERBB2 is a target for USP8-mediated deubiquitination
- (2010) Inez M.J. Meijer et al. CELLULAR SIGNALLING
- Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8·STAM Complex
- (2010) Ilana Berlin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease
- (2010) Shan Qin et al. JOURNAL OF CLINICAL INVESTIGATION
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
- (2009) J. P. Eder et al. CLINICAL CANCER RESEARCH
- Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms
- (2009) Masashi Sanada et al. NATURE
- MET receptor tyrosine kinase as a therapeutic anticancer target
- (2008) Christine M. Stellrecht et al. CANCER LETTERS
- "Active" Cancer Immunotherapy by Anti-Met Antibody Gene Transfer
- (2008) E. Vigna et al. CANCER RESEARCH
- Drug development of MET inhibitors: targeting oncogene addiction and expedience
- (2008) Paolo M. Comoglio et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting ubiquitin specific proteases for drug discovery
- (2007) Laurent Daviet et al. BIOCHIMIE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search